DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RIVASTIGMINE

« Back to Dashboard

Clinical Trials for Rivastigmine

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00099216	Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia	Completed	Novartis Pharmaceuticals	Phase 3	2001-08-01	The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
NCT00099242	Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease	Completed	Novartis	Phase 3	2003-11-01	The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.
NCT00102284	Neuromodulation and Language Acquisition (Project Stage Ia)	Terminated	University Hospital Muenster	Phase 4	2004-03-01	The purpose of this study is to determine whether levodopa, pergolid, rivastigmine, or modafinil are effective in boosting semantic language acquisition in healthy subjects.

Clinical Trial Conditions for Rivastigmine

Condition Name

Condition Name for Rivastigmine
Intervention	Trials
Alzheimer's Disease	28
Alzheimer Disease	10
Delirium	6

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Rivastigmine
Intervention	Trials
Alzheimer Disease	45
Dementia	18
Cognition Disorders	10

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Rivastigmine

Trials by Country

Trials by Country for Rivastigmine
Location	Trials
United States	147
Japan	44
Netherlands	17
Canada	17
Italy	15

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Rivastigmine
Location	Trials
Texas	11
California	10
Florida	9
New York	9
Pennsylvania	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Rivastigmine

Clinical Trial Phase

Clinical Trial Phase for Rivastigmine
Clinical Trial Phase	Trials
Phase 4	33
Phase 3	25
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Rivastigmine
Clinical Trial Phase	Trials
Completed	58
Terminated	7
Unknown status	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Rivastigmine

Sponsor Name

Sponsor Name for Rivastigmine
Sponsor	Trials
Novartis	19
Novartis Pharmaceuticals	14
National Institute on Drug Abuse (NIDA)	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Rivastigmine
Sponsor	Trials
Other	89
Industry	53
NIH	6

Export unavailable in trial.
Subscribe for complete access.